Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation

Tomoko S. Kato, Paolo C. Colombo, Nadav Nahumi, Shuichi Kitada, Hiroo Takayama, Yoshifumi Naka, Marco R. Di Tullio, Shunichi Homma, Donna Mancini, Ulrich P. Jorde, Nir Uriel

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Thrombus formation inside of the pump is a major cause for device malfunction following the left ventricular assist device (LVAD) implantation. We recently established a novel ramp test protocol facilitating continuous bedside echo monitoring to optimize LVAD function and diagnosing device malfunctions. We describe a case of 29-year-old woman undergoing HeartMate II LVAD implantation, in whom serial ramp studies were used to diagnose intra-device thrombus after device implantation. The 1st ramp study at postoperative day (POD) 26 revealed adequate reduction in ventricular size according to the increase in LVAD speed (left ventricular end-diastolic diameter [LVEDD] at minimum and maximum speeds, 68 and 37 mm, respectively). The patient was discharged home and received routine anticoagulation maintenance therapy. However, a 2nd ramp test was performed on POD 56 due to increased lactase dehydrogenase and brain natriuretic peptide levels and showed marked increase in left ventricle (LV) chamber size without adequate response to the LVAD speed changes (LVEDD at minimum and maximum speeds, 88 and 76 mm, respectively). Given the suspicion for partial pump thrombosis, the patient was immediately hospitalized and received intravenous heparin infusion. After the optimization of the intensive anticoagulation therapy, the patient underwent a 3rd ramp study, which showed a remarkable improvement of the adequate response to LVAD speed changes. The patients eventually underwent cardiac transplant successfully, and the partial clot was found inside of the pump. This case demonstrates the usefulness of serial ramp studies in patients who are suspected to have device thrombosis. Mini-Abstract Continuous-flow left ventricular assist devices (CF-LVAD) have become a durable and reliable therapy for patients with heart failure; however, thrombus formation is still one of the main reasons for device malfunction and pump replacement. We recently established a novel approach to optimize CF-LVAD function and diagnose device malfunctions. We describe a case of a 29-year-old woman in whom serial ramp studies were used to diagnose intra-device thrombus after implantation. Anticoagulation was optimized under the guidance of ramp studies until she was successfully transplanted.

Original languageEnglish (US)
JournalEchocardiography
Volume31
Issue number1
DOIs
StatePublished - Jan 2014
Externally publishedYes

Fingerprint

Architectural Accessibility
Heart-Assist Devices
Thrombosis
Equipment and Supplies
Lactase
Brain Natriuretic Peptide
Intravenous Infusions
Heart Ventricles
Heparin
Oxidoreductases
Therapeutics
Heart Failure
Transplants

Keywords

  • echocardiogram
  • heart failure
  • left ventricular assist device
  • thrombus

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation. / Kato, Tomoko S.; Colombo, Paolo C.; Nahumi, Nadav; Kitada, Shuichi; Takayama, Hiroo; Naka, Yoshifumi; Di Tullio, Marco R.; Homma, Shunichi; Mancini, Donna; Jorde, Ulrich P.; Uriel, Nir.

In: Echocardiography, Vol. 31, No. 1, 01.2014.

Research output: Contribution to journalArticle

Kato, TS, Colombo, PC, Nahumi, N, Kitada, S, Takayama, H, Naka, Y, Di Tullio, MR, Homma, S, Mancini, D, Jorde, UP & Uriel, N 2014, 'Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation', Echocardiography, vol. 31, no. 1. https://doi.org/10.1111/echo.12379
Kato, Tomoko S. ; Colombo, Paolo C. ; Nahumi, Nadav ; Kitada, Shuichi ; Takayama, Hiroo ; Naka, Yoshifumi ; Di Tullio, Marco R. ; Homma, Shunichi ; Mancini, Donna ; Jorde, Ulrich P. ; Uriel, Nir. / Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation. In: Echocardiography. 2014 ; Vol. 31, No. 1.
@article{0965eeed4dac4d7095afc4202cb531f0,
title = "Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation",
abstract = "Thrombus formation inside of the pump is a major cause for device malfunction following the left ventricular assist device (LVAD) implantation. We recently established a novel ramp test protocol facilitating continuous bedside echo monitoring to optimize LVAD function and diagnosing device malfunctions. We describe a case of 29-year-old woman undergoing HeartMate II LVAD implantation, in whom serial ramp studies were used to diagnose intra-device thrombus after device implantation. The 1st ramp study at postoperative day (POD) 26 revealed adequate reduction in ventricular size according to the increase in LVAD speed (left ventricular end-diastolic diameter [LVEDD] at minimum and maximum speeds, 68 and 37 mm, respectively). The patient was discharged home and received routine anticoagulation maintenance therapy. However, a 2nd ramp test was performed on POD 56 due to increased lactase dehydrogenase and brain natriuretic peptide levels and showed marked increase in left ventricle (LV) chamber size without adequate response to the LVAD speed changes (LVEDD at minimum and maximum speeds, 88 and 76 mm, respectively). Given the suspicion for partial pump thrombosis, the patient was immediately hospitalized and received intravenous heparin infusion. After the optimization of the intensive anticoagulation therapy, the patient underwent a 3rd ramp study, which showed a remarkable improvement of the adequate response to LVAD speed changes. The patients eventually underwent cardiac transplant successfully, and the partial clot was found inside of the pump. This case demonstrates the usefulness of serial ramp studies in patients who are suspected to have device thrombosis. Mini-Abstract Continuous-flow left ventricular assist devices (CF-LVAD) have become a durable and reliable therapy for patients with heart failure; however, thrombus formation is still one of the main reasons for device malfunction and pump replacement. We recently established a novel approach to optimize CF-LVAD function and diagnose device malfunctions. We describe a case of a 29-year-old woman in whom serial ramp studies were used to diagnose intra-device thrombus after implantation. Anticoagulation was optimized under the guidance of ramp studies until she was successfully transplanted.",
keywords = "echocardiogram, heart failure, left ventricular assist device, thrombus",
author = "Kato, {Tomoko S.} and Colombo, {Paolo C.} and Nadav Nahumi and Shuichi Kitada and Hiroo Takayama and Yoshifumi Naka and {Di Tullio}, {Marco R.} and Shunichi Homma and Donna Mancini and Jorde, {Ulrich P.} and Nir Uriel",
year = "2014",
month = "1",
doi = "10.1111/echo.12379",
language = "English (US)",
volume = "31",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Value of serial echo-guided ramp studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation

AU - Kato, Tomoko S.

AU - Colombo, Paolo C.

AU - Nahumi, Nadav

AU - Kitada, Shuichi

AU - Takayama, Hiroo

AU - Naka, Yoshifumi

AU - Di Tullio, Marco R.

AU - Homma, Shunichi

AU - Mancini, Donna

AU - Jorde, Ulrich P.

AU - Uriel, Nir

PY - 2014/1

Y1 - 2014/1

N2 - Thrombus formation inside of the pump is a major cause for device malfunction following the left ventricular assist device (LVAD) implantation. We recently established a novel ramp test protocol facilitating continuous bedside echo monitoring to optimize LVAD function and diagnosing device malfunctions. We describe a case of 29-year-old woman undergoing HeartMate II LVAD implantation, in whom serial ramp studies were used to diagnose intra-device thrombus after device implantation. The 1st ramp study at postoperative day (POD) 26 revealed adequate reduction in ventricular size according to the increase in LVAD speed (left ventricular end-diastolic diameter [LVEDD] at minimum and maximum speeds, 68 and 37 mm, respectively). The patient was discharged home and received routine anticoagulation maintenance therapy. However, a 2nd ramp test was performed on POD 56 due to increased lactase dehydrogenase and brain natriuretic peptide levels and showed marked increase in left ventricle (LV) chamber size without adequate response to the LVAD speed changes (LVEDD at minimum and maximum speeds, 88 and 76 mm, respectively). Given the suspicion for partial pump thrombosis, the patient was immediately hospitalized and received intravenous heparin infusion. After the optimization of the intensive anticoagulation therapy, the patient underwent a 3rd ramp study, which showed a remarkable improvement of the adequate response to LVAD speed changes. The patients eventually underwent cardiac transplant successfully, and the partial clot was found inside of the pump. This case demonstrates the usefulness of serial ramp studies in patients who are suspected to have device thrombosis. Mini-Abstract Continuous-flow left ventricular assist devices (CF-LVAD) have become a durable and reliable therapy for patients with heart failure; however, thrombus formation is still one of the main reasons for device malfunction and pump replacement. We recently established a novel approach to optimize CF-LVAD function and diagnose device malfunctions. We describe a case of a 29-year-old woman in whom serial ramp studies were used to diagnose intra-device thrombus after implantation. Anticoagulation was optimized under the guidance of ramp studies until she was successfully transplanted.

AB - Thrombus formation inside of the pump is a major cause for device malfunction following the left ventricular assist device (LVAD) implantation. We recently established a novel ramp test protocol facilitating continuous bedside echo monitoring to optimize LVAD function and diagnosing device malfunctions. We describe a case of 29-year-old woman undergoing HeartMate II LVAD implantation, in whom serial ramp studies were used to diagnose intra-device thrombus after device implantation. The 1st ramp study at postoperative day (POD) 26 revealed adequate reduction in ventricular size according to the increase in LVAD speed (left ventricular end-diastolic diameter [LVEDD] at minimum and maximum speeds, 68 and 37 mm, respectively). The patient was discharged home and received routine anticoagulation maintenance therapy. However, a 2nd ramp test was performed on POD 56 due to increased lactase dehydrogenase and brain natriuretic peptide levels and showed marked increase in left ventricle (LV) chamber size without adequate response to the LVAD speed changes (LVEDD at minimum and maximum speeds, 88 and 76 mm, respectively). Given the suspicion for partial pump thrombosis, the patient was immediately hospitalized and received intravenous heparin infusion. After the optimization of the intensive anticoagulation therapy, the patient underwent a 3rd ramp study, which showed a remarkable improvement of the adequate response to LVAD speed changes. The patients eventually underwent cardiac transplant successfully, and the partial clot was found inside of the pump. This case demonstrates the usefulness of serial ramp studies in patients who are suspected to have device thrombosis. Mini-Abstract Continuous-flow left ventricular assist devices (CF-LVAD) have become a durable and reliable therapy for patients with heart failure; however, thrombus formation is still one of the main reasons for device malfunction and pump replacement. We recently established a novel approach to optimize CF-LVAD function and diagnose device malfunctions. We describe a case of a 29-year-old woman in whom serial ramp studies were used to diagnose intra-device thrombus after implantation. Anticoagulation was optimized under the guidance of ramp studies until she was successfully transplanted.

KW - echocardiogram

KW - heart failure

KW - left ventricular assist device

KW - thrombus

UR - http://www.scopus.com/inward/record.url?scp=84891833672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891833672&partnerID=8YFLogxK

U2 - 10.1111/echo.12379

DO - 10.1111/echo.12379

M3 - Article

VL - 31

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

IS - 1

ER -